Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Water balance; normal mechanism, methods of administration, dangers.

Missouri medicine·2010
Same author

Clinical experiences with thiouracil.

Missouri medicine·2010
Same author

Liver extract in the treatment of hepatic cirrhosis.

Proceedings [of the] annual meeting. Central Society for Clinical Research (U.S.)·2010
Same author

Laboratory studies on the aging kidney.

Journal of the American Geriatrics Society·1967
Same author

A monoamine oxidase inhibitor in the treatment of organic disease.

Journal of neuropsychiatry·1961
Same author

Characteristics of influenza virus infections observed in St. Louis from 1943 to 1957; I. Relationship of changes in antigenic composition of influenza viruses to morbidity from influenza.

A.M.A. archives of internal medicine·1958
Same journal

Congestive heart failure.

Journal. Kansas City (Mo.) Southwest Clinical Society·2010
Same journal

Paroxysmal cardiac irregularities.

Journal. Kansas City (Mo.) Southwest Clinical Society·2010
Same journal

Roentgen diagnosis in heart disease.

Journal. Kansas City (Mo.) Southwest Clinical Society·2010
Same journal

Rheumatic fever in children.

Journal. Kansas City (Mo.) Southwest Clinical Society·2010
Same journal

The importance of bronchiogenic carcinoma to the general practitioner.

Journal. Kansas City (Mo.) Southwest Clinical Society·2010
Same journal

Cysts of the mediastinum and lungs.

Journal. Kansas City (Mo.) Southwest Clinical Society·2010
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Immunofluorescent Detection of Two Thymidine Analogues (CldU and IdU) in Primary Tissue
10:55

Immunofluorescent Detection of Two Thymidine Analogues (CldU and IdU) in Primary Tissue

Published on: December 7, 2010

Clinical experiences with thiouracil

R O MUETHER

    Journal. Kansas City (Mo.) Southwest Clinical Society
    |March 19, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    THIOURACIL/therapy

    More Related Videos

    In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
    04:14

    In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

    Published on: October 6, 2023

    Related Experiment Videos

    Last Updated: Jun 15, 2026

    Immunofluorescent Detection of Two Thymidine Analogues (CldU and IdU) in Primary Tissue
    10:55

    Immunofluorescent Detection of Two Thymidine Analogues (CldU and IdU) in Primary Tissue

    Published on: December 7, 2010

    In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
    04:14

    In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

    Published on: October 6, 2023